ticlopidine has been researched along with Anterior Choroidal Artery Infarction in 91 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to evaluate the efficacy and safety of intravenous vinpocetine administration as part of a comprehensive treatment for acute cerebral infarction in a Chinese population." | 9.22 | Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. ( Hu, H; Huang, Y; Kong, Y; Li, C; Li, Y; Nao, J; Song, Y; Tan, L; Zhang, J; Zhang, W, 2016) |
| "Stroke victims often exhibit clopidogrel resistance (CR)." | 9.17 | Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction. ( Deng, YH; Guan, HT; Liu, ZF; Shi, HT; Wang, R; Zhang, M; Zhou, BR, 2013) |
| "Patients with noncardioembolic cerebral infarction were randomized to clopidogrel 75 mg or ticlopidine 200 mg once daily for 52 weeks." | 9.13 | A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. ( Fukuuchi, Y; Hirano, M; Ikeda, Y; Matsumoto, M; Miyanaga, Y; Okudera, T; Shinohara, Y; Tohgi, H; Uchiyama, S; Yamaguchi, T, 2008) |
| "Fluctuations in urinary 11-DTB2 after cerebral infarction in blacks do not correlate with changes in aspirin doses, except perhaps when the dose changes by a factor of 4 or more." | 9.11 | Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. ( Bang, NU; Bruno, A; Cohen, SN; Gorelick, PB; McConnell, JP; Tietjen, GE; Wallis, RA, 2004) |
| "To compare the efficacy and safety of two antiplatelet regimens, ticlopidine alone (200 mg daily) and ticlopidine (100 mg daily) plus aspirin (81 mg daily), in patients with ischemic stroke from the Tokai district of Japan." | 9.10 | Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke. ( Ito, E; Kuzuhara, S; Nakajima, M; Takahashi, A; Uchiyama, S; Yamamoto, H, 2003) |
| "We determined the percentages of fibrinogen-bound and P-selectin-expressed platelets in whole blood using flow cytometry in 254 patients with various cerebral infarction subtypes, as well as in 30 age-matched controls." | 9.09 | Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. ( Iwata, M; Uchiyama, S; Yamazaki, M, 2001) |
| "It seems that these results showed the safety and efficacy of the enteric-coated aspirin in acute stroke care in Japanese patients." | 7.80 | Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan. ( Inuyama, L; Mizuno, O; Sakaguchi, T; Takahashi, S; Yamada, T, 2014) |
| "Acute cerebral ischemia was produced in rats by injection of arachidonic acid (AA) into the internal carotid artery." | 7.68 | Protective effects of benidipine on arachidonic acid-induced acute cerebral ischemia in rats. ( Karasawa, A; Kubo, K; Sano, J; Shirakura, S, 1992) |
| "Our results suggest that ticlopidine can improve the enhanced erythrocyte aggregability in patients with cerebral infarction during the chronic phase." | 7.68 | Ticlopidine improves the enhanced erythrocyte aggregability in patients with cerebral infarction. ( Fukuuchi, Y; Matsuoka, S; Takeda, H; Tanahashi, N; Tomita, M, 1993) |
| " As for intracranial hemorrhage (ICH), stroke recurrence, and adverse event (AE) rate, there were no significant differences of efficacy among 7 drug therapies." | 6.58 | Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction. ( Liu, X; Zhang, JJ, 2018) |
| "The objective of this study was to evaluate the efficacy and safety of intravenous vinpocetine administration as part of a comprehensive treatment for acute cerebral infarction in a Chinese population." | 5.22 | Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. ( Hu, H; Huang, Y; Kong, Y; Li, C; Li, Y; Nao, J; Song, Y; Tan, L; Zhang, J; Zhang, W, 2016) |
| "Stroke victims often exhibit clopidogrel resistance (CR)." | 5.17 | Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction. ( Deng, YH; Guan, HT; Liu, ZF; Shi, HT; Wang, R; Zhang, M; Zhou, BR, 2013) |
| "Patients with noncardioembolic cerebral infarction were randomized to clopidogrel 75 mg or ticlopidine 200 mg once daily for 52 weeks." | 5.13 | A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. ( Fukuuchi, Y; Hirano, M; Ikeda, Y; Matsumoto, M; Miyanaga, Y; Okudera, T; Shinohara, Y; Tohgi, H; Uchiyama, S; Yamaguchi, T, 2008) |
| "Fluctuations in urinary 11-DTB2 after cerebral infarction in blacks do not correlate with changes in aspirin doses, except perhaps when the dose changes by a factor of 4 or more." | 5.11 | Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. ( Bang, NU; Bruno, A; Cohen, SN; Gorelick, PB; McConnell, JP; Tietjen, GE; Wallis, RA, 2004) |
| "To compare the efficacy and safety of two antiplatelet regimens, ticlopidine alone (200 mg daily) and ticlopidine (100 mg daily) plus aspirin (81 mg daily), in patients with ischemic stroke from the Tokai district of Japan." | 5.10 | Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke. ( Ito, E; Kuzuhara, S; Nakajima, M; Takahashi, A; Uchiyama, S; Yamamoto, H, 2003) |
| "We determined the percentages of fibrinogen-bound and P-selectin-expressed platelets in whole blood using flow cytometry in 254 patients with various cerebral infarction subtypes, as well as in 30 age-matched controls." | 5.09 | Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. ( Iwata, M; Uchiyama, S; Yamazaki, M, 2001) |
| "At the acute phase of cerebral infarction, two recent large studies found that the use of aspirin reduces both mortality and the risk of the recurrence of stroke." | 4.80 | [Aspirin and cerebral ischemic accidents]. ( Bousser, MG; Crassard, I; Niclot, P, 2000) |
| "Long-term use of aspirin and severity of cerebral infarction are risk factors for gastrointestinal bleeding in cerebral infarction patients receiving dual antiplatelet therapy." | 4.31 | Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy. ( Huang, J; Liao, F; Shu, X; Tang, J, 2023) |
| "Clopidogrel was administered to a 67-year-old Japanese man to prevent the recurrence of cerebral infarction." | 3.83 | Clopidogrel-induced Thrombotic Microangiopathy in a Patient with Hypocomplementemia. ( Abe, Y; Hamauchi, A; Ito, K; Miyake, K; Nakashima, H; Sasatomi, Y; Tada, K; Takahashi, K; Uchida, A; Watanabe, R; Yasuno, T, 2016) |
| "It seems that these results showed the safety and efficacy of the enteric-coated aspirin in acute stroke care in Japanese patients." | 3.80 | Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan. ( Inuyama, L; Mizuno, O; Sakaguchi, T; Takahashi, S; Yamada, T, 2014) |
| "Co-prescribed aspirin and dipyridamole are more effective than aspirin alone following cerebral infarction; however, patients may struggle with this more complex regimen." | 3.78 | Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort. ( Doney, AS; Flynn, RW; MacDonald, TM; MacWalter, RS; Murray, GD, 2012) |
| "Patients who have had a recent transient ischemic attack (TIA) are at high risk for subsequent stroke." | 3.77 | Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly. ( Adams, HP; Gordon, DL, 1991) |
| " Citrated blood samples were collected from 62 patients with chronic cerebral infarction (CCI), of whom 19 patients were treated with ticlopidine, and from 9 healthy subjects." | 3.72 | Simple, rapid, and automated method for detection of hyperaggregability of platelets using a hematology analyzer. ( Ando, Y; Miyachi, H; Shimizu, M; Shinohara, Y; Yamamoto, M, 2003) |
| "In order to find out the difference between cilostazol and ticlopidine hydrochloride in the cerebral vasodilating effect in the chronic stage of cerebral infarction, cerebral blood flows were measured while the patients were on ticlopidine hydrochloride and after ticlopidine hydrochloride was switched to cilostazol." | 3.70 | Effect of cilostazol on cerebral blood flows in chronic stage of cerebral circulation. ( Mochizuki, Y; Oishi, M; Satoh, Y; Shikata, E, 2000) |
| " We report a patient with long-standing psoriasis vulgaris who showed rapid improvement during agranulocytosis caused by ticlopidine." | 3.70 | Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis. ( Furukawa, F; Tachibana, T; Toichi, E, 2000) |
| "Elevated levels of plasma fibrinogen are a risk factor for cerebral infarction." | 3.69 | Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin. ( Kashiwaya, M; Takahashi, H; Tohgi, H; Watanabe, K, 1994) |
| "Our results suggest that ticlopidine can improve the enhanced erythrocyte aggregability in patients with cerebral infarction during the chronic phase." | 3.68 | Ticlopidine improves the enhanced erythrocyte aggregability in patients with cerebral infarction. ( Fukuuchi, Y; Matsuoka, S; Takeda, H; Tanahashi, N; Tomita, M, 1993) |
| "A 63-year-old woman was referred to our division because of massive hemoptysis (200 ml) after administration of ticlopidine, an anti-thrombotic drug, for prevention of recurrent brain infarction." | 3.68 | [A case of hemoptysis due to administration of an anti-thrombotic drug]. ( Hashiguchi, K; Kawane, H; Soejima, R; Umeki, S; Wakunami, M; Yagi, S, 1990) |
| "Acute cerebral ischemia was produced in rats by injection of arachidonic acid (AA) into the internal carotid artery." | 3.68 | Protective effects of benidipine on arachidonic acid-induced acute cerebral ischemia in rats. ( Karasawa, A; Kubo, K; Sano, J; Shirakura, S, 1992) |
| "The 40 patients with cerebral infarction were randomly divided into aspirin-treated group (20 cases) and clopidogrel-treated group (20 cases) scandinavian neurological stroke score (SNSS), plasma sP-sel, serum CRP, PAR and PLA were observed before and after the treatment." | 2.73 | [The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction]. ( Cao, YJ; Feng, P; Liu, CF; Wang, YM, 2007) |
| "The subjects were 75 patients with cerebral ischemia and 26 control subjects." | 2.67 | Shear-induced platelet aggregation in cerebral ischemia. ( Fukuyama, M; Handa, M; Ikeda, Y; Itagaki, I; Maruyama, S; Uchiyama, S; Yamazaki, M, 1994) |
| " As for intracranial hemorrhage (ICH), stroke recurrence, and adverse event (AE) rate, there were no significant differences of efficacy among 7 drug therapies." | 2.58 | Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction. ( Liu, X; Zhang, JJ, 2018) |
| "In the chronic stage of cerebral infarction, monotherapy (aspirin, clopidogrel or cilostazol) is recommended." | 2.50 | [Antiplatelet therapy for secondary prevention of cerebral infarction]. ( Tanahashi, N, 2014) |
| " A loading dosage of aspirin (500 mg) and/or clopidogrel (300 mg) was given 24 hours before the procedure to patients naïve to antiplatelet agents, whereas the usual dosage (aspirin 100 mg and clopidogrel 75 mg) was continued for patients who had previously been taking these agents for more than a week." | 1.40 | Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting. ( Jung, JM; Kang, DW; Kim, BJ; Kim, JS; Kwon, JY; Kwon, SU; Lee, DH, 2014) |
| "Cerebral infarction is a major cause of death or decreasing activities of daily living." | 1.38 | Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol. ( Abe, K; Deguchi, K; Kawai, H; Kurata, T; Ohta, Y; Omote, Y; Tian, F; Yamashita, T, 2012) |
| "He was diagnosed as idiopathic cerebral infarction." | 1.35 | [Recurrent idiopathic cerebral infarction in a 5-year-old boy, with emphasis on the importance of platelet aggregation analysis for appropriate selection of anti-platelet drugs]. ( Ikegami, M; Matsuda, S; Miyashita, Y; Obara, S; Shimizu, M; Sugiyama, N; Takagi, S; Takizawa, S; Yokoyama, J, 2009) |
| "We reported a Japanese first case of thrombotic thrombocytopenic purpura (TTP) induced by clopidogrel, a newly developed antithrombotic drug, marketed in May 2006 in Japan." | 1.34 | [Case of thrombotic thrombocytopenic purpura associated with clopidogrel]. ( Fujimura, Y; Fukusako, T; Matsuda, K; Omoto, M; Shinohara, K; Yamashita, H, 2007) |
| "The dorso-lateral medullary syndrome (Wallenberg's syndrome) is produced by infarction of a wedge of lateral medulla posterior to the inferior olivary nucleus and is usually caused by vertebral artery occlusion." | 1.33 | The clinical variability of Wallenberg's syndrome. The anatomical correlate of ipsilateral axial lateropulsion. ( Nowak, DA; Topka, HR, 2006) |
| "We present a patient with type 2 diabetes mellitus, arterial hypertension and hyperlipidaemia, who had simultaneous oculomotor and trochlear nerve palsies." | 1.33 | Simultaneous, painless, homolateral oculomotor and trochlear nerve palsies in a patient with type 2 diabetes mellitus. Neuropathy or brainstem infarction? ( Heliopoulos, I; Maltezos, E; Papanas, N; Piperidou, H, 2006) |
| "Cerebral ischemia was mechanically induced by 2-hour occlusion of the left middle cerebral artery (MCA) using an intraluminal filament followed by 24-hour reperfusion." | 1.33 | Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats. ( Hong, KW; Lee, JH; Lee, WS; Park, SY, 2005) |
| "Most patients with PAD die of either heart attacks or strokes and they die of the former conditions far earlier than controls." | 1.32 | [Antiplatelet therapy in patients with peripheral arterial disease (PAD)]. ( Diehm, C; Huber, R; Lawall, H, 2004) |
| "Rectal sheath hematoma has been a well-known clinical entity from the ruin of the ancient Greece." | 1.31 | Rectus sheath hematoma in an elderly woman under anti-coagulant therapy. ( Ishikawa, M; Miki, H; Miyauchi, T, 2001) |
| "Most of cerebral infarctions were observed in the hemisphere, ipsilateral to the irradiated carotid artery." | 1.29 | Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits. ( Fujimura, M; Mikashima, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.10) | 18.7374 |
| 1990's | 20 (21.98) | 18.2507 |
| 2000's | 43 (47.25) | 29.6817 |
| 2010's | 23 (25.27) | 24.3611 |
| 2020's | 4 (4.40) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, R | 1 |
| Zhou, W | 1 |
| Ye, Y | 1 |
| Zhang, X | 1 |
| Liu, Y | 1 |
| Wu, J | 1 |
| Deguchi, I | 1 |
| Osada, T | 1 |
| Takahashi, S | 2 |
| Huang, J | 1 |
| Liao, F | 1 |
| Tang, J | 1 |
| Shu, X | 1 |
| Hankey, GJ | 1 |
| Pothukuchi, VK | 1 |
| Kumar, A | 1 |
| Teja, C | 1 |
| Verma, A | 1 |
| Zhang, JJ | 1 |
| Liu, X | 1 |
| Dersch, R | 1 |
| Anastasopoulos, C | 1 |
| Hader, C | 1 |
| Stich, O | 1 |
| Park, KM | 1 |
| Kim, SE | 2 |
| Shin, KJ | 1 |
| Park, J | 1 |
| Kim, HC | 1 |
| Mun, CW | 1 |
| Ha, SY | 1 |
| Zhou, BR | 1 |
| Shi, HT | 1 |
| Wang, R | 1 |
| Zhang, M | 1 |
| Guan, HT | 1 |
| Liu, ZF | 1 |
| Deng, YH | 1 |
| Mizuno, O | 1 |
| Sakaguchi, T | 1 |
| Yamada, T | 1 |
| Inuyama, L | 1 |
| Yamamoto, Y | 1 |
| Kim, BJ | 2 |
| Kwon, JY | 1 |
| Jung, JM | 1 |
| Lee, DH | 2 |
| Kang, DW | 2 |
| Kim, JS | 2 |
| Kwon, SU | 3 |
| Tanahashi, N | 2 |
| Nishihira, T | 1 |
| Suzuki, K | 1 |
| Takekawa, H | 1 |
| Nakamura, T | 1 |
| Iwasaki, A | 1 |
| Hirata, K | 1 |
| Wilson, LK | 1 |
| Pearce, LA | 1 |
| Arauz, A | 1 |
| Anderson, DC | 1 |
| Tapia, J | 1 |
| Bazan, C | 1 |
| Benavente, OR | 1 |
| Field, TS | 1 |
| Tada, K | 1 |
| Ito, K | 1 |
| Hamauchi, A | 1 |
| Takahashi, K | 1 |
| Watanabe, R | 1 |
| Uchida, A | 1 |
| Abe, Y | 1 |
| Yasuno, T | 1 |
| Miyake, K | 1 |
| Sasatomi, Y | 1 |
| Nakashima, H | 1 |
| Zhang, W | 1 |
| Huang, Y | 1 |
| Li, Y | 1 |
| Tan, L | 1 |
| Nao, J | 1 |
| Hu, H | 1 |
| Zhang, J | 2 |
| Li, C | 1 |
| Kong, Y | 1 |
| Song, Y | 1 |
| Koziol, K | 1 |
| Van der Merwe, V | 1 |
| Yakiwchuk, E | 1 |
| Kosar, L | 1 |
| Einecke, D | 2 |
| Sugiyama, N | 1 |
| Matsuda, S | 1 |
| Shimizu, M | 2 |
| Obara, S | 1 |
| Ikegami, M | 1 |
| Yokoyama, J | 1 |
| Miyashita, Y | 1 |
| Takizawa, S | 1 |
| Takagi, S | 1 |
| Yamasaki, H | 1 |
| Matsubara, S | 1 |
| Sasaki, I | 1 |
| Nagahiro, S | 1 |
| Yoshii, F | 1 |
| Serebruany, VL | 1 |
| Meves, SH | 1 |
| Overbeck, U | 1 |
| Kaiser, A | 1 |
| Krogias, C | 1 |
| Neubauer, H | 1 |
| Khemasuwan, D | 1 |
| Chae, YK | 1 |
| Gupta, S | 1 |
| Carpio, A | 1 |
| Yun, JH | 1 |
| Neagu, S | 1 |
| Lucca, AB | 1 |
| Valsecchi, ME | 1 |
| Mora, JI | 1 |
| Lee, SW | 1 |
| Park, SW | 1 |
| Flynn, RW | 1 |
| MacDonald, TM | 1 |
| Murray, GD | 1 |
| MacWalter, RS | 1 |
| Doney, AS | 1 |
| Weber, R | 2 |
| Weimar, C | 1 |
| Wanke, I | 1 |
| Möller-Hartmann, C | 1 |
| Gizewski, ER | 1 |
| Blatchford, J | 1 |
| Hermansson, K | 1 |
| Demchuk, AM | 1 |
| Forsting, M | 1 |
| Sacco, RL | 1 |
| Saver, JL | 1 |
| Warach, S | 1 |
| Diener, HC | 4 |
| Diehl, A | 1 |
| Omote, Y | 1 |
| Deguchi, K | 1 |
| Tian, F | 1 |
| Kawai, H | 1 |
| Kurata, T | 1 |
| Yamashita, T | 1 |
| Ohta, Y | 1 |
| Abe, K | 1 |
| Roberton, A | 1 |
| Shinton, R | 1 |
| Clow, L | 1 |
| Tudway, D | 1 |
| Meyer, S | 1 |
| Yamamoto, M | 1 |
| Miyachi, H | 1 |
| Shinohara, Y | 3 |
| Ando, Y | 1 |
| Steiger, D | 1 |
| Ito, E | 1 |
| Takahashi, A | 1 |
| Yamamoto, H | 1 |
| Kuzuhara, S | 1 |
| Uchiyama, S | 6 |
| Nakajima, M | 1 |
| Georgiadis, D | 1 |
| Michel, P | 1 |
| Bogousslavsky, J | 1 |
| Baumgartner, RW | 1 |
| Bruno, A | 2 |
| McConnell, JP | 1 |
| Cohen, SN | 1 |
| Tietjen, GE | 1 |
| Wallis, RA | 1 |
| Gorelick, PB | 1 |
| Bang, NU | 1 |
| Diehm, C | 1 |
| Lawall, H | 1 |
| Huber, R | 1 |
| Stiefelhagen, P | 1 |
| Hamano, T | 1 |
| Hiraki, S | 1 |
| Kawamura, Y | 1 |
| Hirayama, M | 1 |
| Mutoh, T | 1 |
| Kuriyama, M | 1 |
| Lee, JH | 2 |
| Park, SY | 1 |
| Lee, WS | 1 |
| Hong, KW | 1 |
| Yamagami, H | 1 |
| Kitagawa, K | 1 |
| Ohtsuki, T | 1 |
| Matsumoto, M | 2 |
| Hori, M | 1 |
| Nowak, DA | 1 |
| Topka, HR | 1 |
| Calvet, D | 1 |
| Touzé, E | 1 |
| Mas, JL | 1 |
| Papanas, N | 1 |
| Heliopoulos, I | 1 |
| Piperidou, H | 1 |
| Maltezos, E | 1 |
| Leys, D | 1 |
| Cordonnier, C | 1 |
| Mayr, FB | 1 |
| Jilma, B | 1 |
| Kummer, O | 1 |
| Haschke, M | 1 |
| Tuchscherer, D | 1 |
| Lampert, M | 1 |
| Martius, F | 1 |
| Krähenbühl, S | 1 |
| Pyun, HW | 1 |
| Choi, CG | 1 |
| Kim, SJ | 1 |
| Suh, DC | 1 |
| Tohgi, H | 4 |
| Grond, M | 1 |
| Wang, YM | 2 |
| Cao, YJ | 2 |
| Liu, CF | 2 |
| Feng, P | 1 |
| Fukuuchi, Y | 2 |
| Okudera, T | 1 |
| Ikeda, Y | 2 |
| Miyanaga, Y | 1 |
| Hirano, M | 1 |
| Yamaguchi, T | 1 |
| Fukusako, T | 1 |
| Yamashita, H | 1 |
| Omoto, M | 1 |
| Matsuda, K | 1 |
| Shinohara, K | 1 |
| Fujimura, Y | 1 |
| Zeng, YJ | 1 |
| Imura, Y | 1 |
| Kiyota, Y | 1 |
| Nagai, Y | 1 |
| Nishikawa, K | 1 |
| Terashita, Z | 1 |
| Weiner, P | 1 |
| Zidan, F | 1 |
| Paz, R | 1 |
| Komiya, T | 1 |
| Kudo, M | 1 |
| Urabe, T | 1 |
| Mizuno, Y | 1 |
| Busse, O | 1 |
| Chiba, K | 1 |
| Takahashi, H | 2 |
| Tamura, K | 1 |
| Sasaki, K | 1 |
| Suzuki, H | 1 |
| Yamazaki, M | 3 |
| Maruyama, S | 1 |
| Handa, M | 1 |
| Fukuyama, M | 1 |
| Itagaki, I | 1 |
| Kashiwaya, M | 1 |
| Watanabe, K | 1 |
| Weiller, C | 1 |
| Tomita, M | 1 |
| Matsuoka, S | 1 |
| Takeda, H | 1 |
| Fujimura, M | 1 |
| Mikashima, H | 1 |
| Green, D | 1 |
| Bechich, S | 1 |
| Arboix, A | 1 |
| Wegmann, C | 1 |
| Münzenmaier, R | 1 |
| Dormann, AJ | 1 |
| Huchzermeyer, H | 1 |
| Pizzulli, L | 1 |
| Lüderitz, B | 1 |
| Carlsson, J | 1 |
| Miketic, S | 1 |
| Bätge, R | 1 |
| Riedel, P | 1 |
| Rahlf, G | 1 |
| Tebbe, U | 1 |
| Oishi, M | 1 |
| Mochizuki, Y | 1 |
| Shikata, E | 1 |
| Satoh, Y | 1 |
| Crassard, I | 1 |
| Niclot, P | 1 |
| Bousser, MG | 1 |
| Toichi, E | 1 |
| Tachibana, T | 1 |
| Furukawa, F | 1 |
| Mesec, A | 1 |
| Rot, U | 1 |
| Grad, A | 1 |
| Haldemann, R | 1 |
| Lüscher, TF | 1 |
| Szucs, TD | 1 |
| Iwata, M | 2 |
| Miyauchi, T | 1 |
| Ishikawa, M | 1 |
| Miki, H | 1 |
| Haberl, R | 1 |
| Shirakura, S | 1 |
| Sano, J | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Ishikawa, T | 1 |
| Sasaki, H | 1 |
| Makino, K | 1 |
| Gotoh, S | 1 |
| Takamura, H | 1 |
| Takei, H | 1 |
| Hattori, A | 1 |
| Adams, HP | 1 |
| Gordon, DL | 1 |
| Wakunami, M | 1 |
| Umeki, S | 1 |
| Hashiguchi, K | 1 |
| Yagi, S | 1 |
| Kawane, H | 1 |
| Soejima, R | 1 |
| Zorzon, M | 1 |
| Monti, F | 1 |
| Del Pio Luogo, T | 1 |
| Cazzato, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Secondary Prevention of Small Subcortical Strokes (SPS3) Trial[NCT00059306] | Phase 3 | 3,020 participants (Actual) | Interventional | 2003-02-28 | Completed | ||
| PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis[NCT00153062] | Phase 4 | 20,332 participants (Actual) | Interventional | 2003-08-31 | Completed | ||
| Antiplatelet Therapy in Secondary Prevention for Patient With Silent Brain Infarction[NCT03318744] | 3,400 participants (Anticipated) | Interventional | 2018-01-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of patients with any of stroke, myocardial infarction, vascular death (NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Aspirin + Extended Release Dipyridamole | 1333 |
| Clopidogrel | 1333 |
Number of patients with any of stroke, myocardial infarction, vascular death, or new or worsening congestive heart failure (NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 1367 |
| Placebo | 1463 |
(NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Aspirin + Extended Release Dipyridamole | 916 |
| Clopidogrel | 898 |
(NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 880 |
| Placebo | 934 |
(NCT00153062)
Timeframe: Randomization to final patient contact
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 125 |
| Placebo | 151 |
16 reviews available for ticlopidine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hema | 2018 |
[Concept, pathophysiology and treatment for branch atheromatous disease].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Clopidogrel; Contraindications; Drug Therapy, | 2014 |
[Antiplatelet therapy for secondary prevention of cerebral infarction].
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Humans; Japan; Platelet Aggreg | 2014 |
Dual antiplatelet therapy for secondary stroke prevention: Use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke.
Topics: Aged, 80 and over; Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Female; Hum | 2016 |
[Treatment of acute stroke -- an overview].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Brain Edema; Case-Control Studies; Cereb | 2003 |
[EBM of cerebral infarction: message from mega-studies].
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Cerebral Infarction; Clopidogrel; Dipyridamole; D | 2003 |
[Adding aspirin to clopidogrel in secondary prevention of ischemic stroke: no significant benefits. Results of the Match study].
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Follow-Up Studies; Hemorrhage; | 2006 |
Current developments in anti-platelet therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cerebral Infarction; Clopidogrel; Drug Resistance; | 2006 |
[Ticlopidine].
Topics: Cerebral Infarction; Clinical Trials as Topic; Platelet Aggregation Inhibitors; Recurrence; Ticlopid | 2006 |
[Clopidogrel].
Topics: Cerebral Infarction; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
[Current aspects of secondary prevention of ischemic stroke].
Topics: Aspirin; Cerebral Infarction; Cholesterol, LDL; Clopidogrel; Delayed-Action Preparations; Dipyridamo | 2007 |
[Ticlopidine. Secondary prevention of ischemic cerebral infarct].
Topics: Adult; Aged; Cerebral Infarction; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female | 1993 |
[Aspirin and cerebral ischemic accidents].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Infarction; Clinica | 2000 |
[Prevention of recurrence in cerebral infarction].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebral Infarction; Drug Therapy, C | 2002 |
Pediatric brain stem infarction caused by a basilar and vertebral artery occlusion: case report.
Topics: Brain Stem; Cerebral Angiography; Cerebral Infarction; Child; Combined Modality Therapy; Hemodilutio | 1992 |
Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Fem | 1991 |
14 trials available for ticlopidine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.
Topics: Aged; Aged, 80 and over; Cerebral Infarction; Cholesterol; Clopidogrel; Female; Follow-Up Studies; H | 2013 |
Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.
Topics: Antihypertensive Agents; Aspirin; Cerebral Infarction; Clopidogrel; Constriction, Pathologic; Double | 2016 |
Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Infarction; Cerebrovascular Circulation; China; Clopidogrel; | 2016 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke.
Topics: Adult; Aged; Aspirin; Cerebral Infarction; Drug Therapy, Combination; Female; Humans; Ischemic Attac | 2003 |
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Black People; Cerebral Infarction; Dose-Response R | 2004 |
[The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction].
Topics: Aged; Aspirin; C-Reactive Protein; Cerebral Infarction; Clopidogrel; Female; Humans; Male; Middle Ag | 2007 |
A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction.
Topics: Aged; Cerebral Infarction; Clopidogrel; Disease-Free Survival; Double-Blind Method; Female; Humans; | 2008 |
The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction.
Topics: Aged; Aspirin; Blood Platelets; Cell Adhesion; Cerebral Infarction; Clopidogrel; Female; Humans; Leu | 2009 |
Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Infarction; Collagen; Drug Monitoring; Female; Follow | 1994 |
Comparison of symptomatic and asymptomatic reinfarctions after small subcortical stroke.
Topics: Aged; Aspirin; Cerebral Angiography; Cerebral Infarction; Cholesterol, HDL; Female; Fibrinogen; Foll | 1994 |
Shear-induced platelet aggregation in cerebral ischemia.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; beta-Thromboglobulin; Brain Ischemia; Cerebral Infarction; | 1994 |
Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cerebral Infarction; Drug Therapy, Combina | 2001 |
Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Fem | 1991 |
62 other studies available for ticlopidine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China.
Topics: Aged; Aspirin; Cerebral Infarction; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; | 2022 |
Efficacy of Treatment with and without Initial Clopidogrel Loading in Branch Atheromatous Disease.
Topics: Cerebral Infarction; Clopidogrel; Humans; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; | 2023 |
Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy.
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; H | 2023 |
CSPS.com Trial of Adding Cilostazol to Antiplatelet Therapy to Reduce Recurrent Stroke.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Drug Therapy, Combination; Female; Humans; Male; Middle Ag | 2020 |
A Rare Case Series of Ischemic Stroke Following Russell's Viper Snake Bite in India.
Topics: Aged; Animals; Antivenins; Cerebral Infarction; Clopidogrel; Daboia; Humans; India; Male; Middle Age | 2017 |
Vertebral artery dissection associated with sildenafil abuse.
Topics: Anticoagulants; Cerebral Infarction; Clopidogrel; Heparin; Humans; Magnetic Resonance Imaging; Male; | 2013 |
Isolated foot drop in acute infarction of the supplementary motor area.
Topics: Brain Ischemia; Cerebral Angiography; Cerebral Infarction; Clopidogrel; Diffusion Magnetic Resonance | 2013 |
Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Cilostazol; Dipyridamole | 2014 |
Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting.
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Resistance; Endovascular Procedures; Female; Humans; | 2014 |
[Lateral medullary infarction presenting with truncal lateropulsion and decreased pain and temperature sensation below T10 sensory level].
Topics: Antipyrine; Arginine; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Edaravone; Free R | 2014 |
Clopidogrel-induced Thrombotic Microangiopathy in a Patient with Hypocomplementemia.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Aged; Anemia, Hemolytic; Cerebral Infarction; Clopidog | 2016 |
[ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Germany; Humans; | 2008 |
[Recurrent idiopathic cerebral infarction in a 5-year-old boy, with emphasis on the importance of platelet aggregation analysis for appropriate selection of anti-platelet drugs].
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Tests; Cerebral Infarction; Child, Preschool; Cilo | 2009 |
Retinal artery embolization during carotid angioplasty and carotid artery stenting: case report.
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Antipyrine; Aspirin; Carotid Artery, External; Carotid S | 2009 |
[Clopidogrel-associated thrombotic thrombocytopenic purpura].
Topics: ADAM Proteins; ADAMTS13 Protein; Autoantibodies; Cerebral Infarction; Clopidogrel; Humans; Platelet | 2009 |
Delays of event adjudication in the TRITON trial.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cerebral Infarction; Clopidogrel; Coronary | 2010 |
[Switching from clopidogrel hydrogen sulfate to clopidogrel besylate. Impaired antiplatelet effect in patients with ischemic stroke].
Topics: Aged; Cerebral Infarction; Clopidogrel; Drug Resistance; Humans; Ischemic Attack, Transient; Male; N | 2010 |
Dose-related effect of statins in venous thrombosis risk reduction.
Topics: Aged; Aspirin; Atherosclerosis; Cerebral Infarction; Clopidogrel; Cohort Studies; Cross-Sectional St | 2011 |
Insufficient platelet inhibition is related to silent embolic cerebral infarctions after coronary angiography.
Topics: Aged; Aspirin; Atherosclerosis; Basilar Artery; Carotid Arteries; Cerebral Infarction; Clopidogrel; | 2012 |
Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort.
Topics: Aged; Aspirin; Cerebral Infarction; Clopidogrel; Cohort Studies; Dipyridamole; Drug Prescriptions; D | 2012 |
Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol.
Topics: Animals; Aspirin; Biomarkers; Cerebral Infarction; Cilostazol; Clopidogrel; Hippocampus; Male; Nerve | 2012 |
Cerebral infarction following a carotid Doppler ultrasound: a chance association?
Topics: Biomarkers; Cerebral Infarction; Clopidogrel; Coronary Angiography; Echocardiography; Female; Humans | 2012 |
[Platelet inhibition in clinical practice].
Topics: Aged; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Clo | 2012 |
[New US guidelines. Myocardial infarct is now treated more aggressively].
Topics: Angina, Unstable; Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Humans; Myoc | 2002 |
Simple, rapid, and automated method for detection of hyperaggregability of platelets using a hematology analyzer.
Topics: Aged; Anticoagulants; Automation; Blood Cell Count; Cerebral Infarction; Chronic Disease; Citric Aci | 2003 |
[Secondary prevention after ischemic stroke].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Cerebral Infarction; Clinical Trials as | 2003 |
[Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
Topics: Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Hemo | 2004 |
[For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
Topics: Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Com | 2004 |
[Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
Topics: Arterial Occlusive Diseases; Aspirin; Cause of Death; Cerebral Infarction; Clopidogrel; Coronary Art | 2004 |
[Secondary prevention after ischemic stroke. High risk patients need special protection].
Topics: Arteriosclerosis; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Humans; Intra | 2004 |
[Primary and secondary prevention of stroke. Prevention is better than healing].
Topics: Aged; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy | 2004 |
Acquired stuttering secondary to callosal infarction.
Topics: Aged; Atrophy; Cerebral Cortex; Cerebral Infarction; Corpus Callosum; Female; Functional Laterality; | 2005 |
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats.
Topics: Animals; Antioxidants; Antipyrine; Aspirin; bcl-2-Associated X Protein; Blotting, Western; Brain Ede | 2005 |
Embolic cerebral infarction caused by intraluminal thrombus in the carotid siphon successfully treated with combination of anticoagulant and antiplatelet drugs.
Topics: Anticoagulants; Cerebral Infarction; Drug Therapy, Combination; Heparin; Humans; Intracranial Thromb | 2005 |
The clinical variability of Wallenberg's syndrome. The anatomical correlate of ipsilateral axial lateropulsion.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain; Cerebral Infarction; Clopidogrel; Dipyridam | 2006 |
Simultaneous, painless, homolateral oculomotor and trochlear nerve palsies in a patient with type 2 diabetes mellitus. Neuropathy or brainstem infarction?
Topics: Aged; Cerebral Infarction; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic N | 2006 |
[Prevention of vascular events after transient ischemic attack or cerebral infarct].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug | 2006 |
[Agranulocytosis in a patient treated with metamizole and clopidogrel].
Topics: Aged; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; Cerebral Infarction; Cl | 2006 |
Internal carotid artery stenosis with ipsilateral persistent hypoglossal artery presenting as a multiterritorial embolic infarction: a case report.
Topics: Aged; Aspirin; Basilar Artery; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarctio | 2007 |
[Case of thrombotic thrombocytopenic purpura associated with clopidogrel].
Topics: Aged, 80 and over; Cerebral Infarction; Clopidogrel; Fatal Outcome; Female; Humans; Plasma Exchange; | 2007 |
Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model.
Topics: Animals; Aspirin; Brain Chemistry; Brain Edema; Cerebral Arteries; Cerebral Infarction; Drug Evaluat | 1995 |
Severe aplastic anemia due to ticlopidine.
Topics: Aged; Anemia, Aplastic; Cerebral Infarction; Female; Humans; Ticlopidine | 1995 |
[Thrombocyte function inhibitors in stroke prevention. Ticlopidine as an alternative to acetylsalicylic acid].
Topics: Aspirin; Cerebral Infarction; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation; Ra | 1994 |
Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Collagen; Fema | 1994 |
Ticlopidine improves the enhanced erythrocyte aggregability in patients with cerebral infarction.
Topics: Adult; Aged; Cerebral Infarction; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; M | 1993 |
Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits.
Topics: Animals; Aspirin; Carotid Artery Thrombosis; Carotid Stenosis; Cerebral Infarction; Disease Models, | 1993 |
Ischemic stroke, Part 2: Optimal treatment and prevention.
Topics: Aged; Aspirin; Brain Edema; Brain Ischemia; Cerebral Infarction; Heparin; Humans; Recurrence; Risk F | 1993 |
CAPRIE trial.
Topics: Anemia, Aplastic; Cerebral Infarction; Clopidogrel; Humans; Male; Middle Aged; Platelet Aggregation | 1997 |
[Significant regression of neurological hemispheric deficit].
Topics: Acute Disease; Aged; Cerebral Infarction; Embolism; Female; Heart; Humans; Platelet Aggregation Inhi | 1997 |
[Ticlopidine-induced acute cholestatic hepatitis].
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Biopsy; Cerebell | 1998 |
[Secondary prevention of recurrent transient ischemic attacks].
Topics: Anticoagulants; Aspirin; Cerebral Infarction; Drug Therapy, Combination; Female; Humans; Ischemic At | 1998 |
[Ticlopidine-associated thrombotic thrombocytopenic purpura (Morbus Moschcowitz)].
Topics: Aged; Brain Ischemia; Cerebral Infarction; Diagnosis, Differential; Fatal Outcome; Female; Humans; P | 2000 |
Effect of cilostazol on cerebral blood flows in chronic stage of cerebral circulation.
Topics: Aged; Carotid Arteries; Cerebral Infarction; Cerebrovascular Circulation; Chronic Disease; Cilostazo | 2000 |
Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis.
Topics: Aged; Agranulocytosis; Biopsy; Cerebral Infarction; Humans; Leukocyte Count; Male; Neutrophils; Plat | 2000 |
Cerebrovascular disease associated with marijuana abuse: a case report.
Topics: Adult; Brain; Brain Ischemia; Cerebral Infarction; Fibrinolytic Agents; Humans; Magnetic Resonance I | 2001 |
[Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study].
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Clopido | 2001 |
Rectus sheath hematoma in an elderly woman under anti-coagulant therapy.
Topics: Abdomen, Acute; Abdominal Pain; Aged; Anticoagulants; Cerebral Infarction; Cough; Diagnosis, Differe | 2001 |
[Risk improves effectiveness. Proper administration of platelet aggregation inhibitors].
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhib | 2002 |
Protective effects of benidipine on arachidonic acid-induced acute cerebral ischemia in rats.
Topics: Animals; Arachidonic Acid; Benzoquinones; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Calcium | 1992 |
[Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction | 1992 |
[A case of hemoptysis due to administration of an anti-thrombotic drug].
Topics: Cerebral Infarction; Female; Hemoptysis; Humans; Middle Aged; Platelet Aggregation Inhibitors; Recur | 1990 |
[Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients].
Topics: Acute Disease; Aged; Cerebral Infarction; Drug Therapy, Combination; Female; Follow-Up Studies; Huma | 1987 |